Request early access information
The TrueMark Respiratory Panel 2.0, TaqMan Array Card, has been updated with targets for today’s critical pathogens, so you get even more answers the first time. With extended coverage that includes SARS-CoV-2 targets, this panel features the most respiratory pathogen targets of any test on the market, at the lowest cost per sample, to help you identify key respiratory infections and study SARS-CoV-2 co-infections quickly and cost-effectively.
Would you like early access to this new panel prior to its official release?
Become an early adopter to gain access to the following features:
- Extensive coverage including SARS-CoV-2 targets—with 42 verified assays, our solution features the largest number of pathogen targets of any panel on the market
- Cost-effective—lowest cost per sample when compared to other commercially available molecular solutions
- Multiple sample input types—including nasopharyngeal (NP) swabs, bronchoalveolar lavage (BAL), and nasal aspirate